Prescription medication · Serotonin-Norepinephrine Reuptake Inhibitor (SNRI)
levomilnacipran
Also sold as Fetzima. Fetzima is used to treat major depressive disorder (MDD) in adults.
Data updated 2026-05-15
- 1,858
- FDA reportsRarely reported
- 11
- InteractionsSeveral interactions
- $16.13
- Brand price (NADAC)
What the data shows
levomilnacipran (Fetzima) is a prescription Serotonin-Norepinephrine Reuptake Inhibitor (SNRI), among the least-reported drugs the FDA tracks (1,858 FDA reports), with 11 documented drug interactions.
Reporting volume reflects how widely a drug is used and studied, not how dangerous it is, a FAERS report documents a temporal association, never proof of cause.
levomilnacipran (Fetzima) is a prescription Serotonin-Norepinephrine Reuptake Inhibitor (SNRI). Fetzima is used to treat major depressive disorder (MDD) in adults.
Fetzima is a medicine used to treat major depressive disorder (MDD) in adults. It helps to improve your mood by affecting certain chemicals in the brain.
Verify with FDA → · CMS NADAC pricing →
Drug Pricing (NADAC)
Brand Price
$16.13/unit
Generic Available
No
ABBVIE
Pricing data from NADAC (CMS), effective January 2, 2024. Compare all drug costs →
What it does
Fetzima is used to treat major depressive disorder (MDD) in adults.
Common side effects
Nausea, Constipation, Increased sweating
Key warnings
Antidepressants may increase the risk of suicidal thoughts and behaviors in young adults.
The sections below are summarized in plain English from levomilnacipran's FDA-approved prescribing information. They describe what the official label says, and are not personal medical advice.
How It Works
Fetzima is a type of drug called a serotonin-norepinephrine reuptake inhibitor (SNRI). It works by increasing the levels of serotonin and norepinephrine in your brain. These chemicals can help improve your mood and reduce symptoms of depression.
How to Take It
Take Fetzima exactly as your doctor tells you to. The usual dose is between 40 mg and 120 mg once a day. You can take it with or without food. Swallow the capsule whole; do not crush, chew, or open it.
This is a plain-language summary of levomilnacipran's FDA labeling, not individualized dosing advice. Ask a pharmacist or prescriber before changing how you take this medication.
Pregnancy & Breastfeeding
Tell your doctor if you are pregnant or plan to become pregnant. Using Fetzima in the last months of pregnancy may cause problems in the newborn. There is a pregnancy registry for women who take antidepressants during pregnancy.
This is a plain-language summary of levomilnacipran's FDA labeling, not individualized advice. Ask a pharmacist or prescriber about pregnancy or breastfeeding on this medication.
Missed Dose
If you miss a dose, take it as soon as you remember. If it is close to your next dose, skip the missed dose and continue with your regular schedule.
This is a plain-language summary of levomilnacipran's FDA labeling, not individualized advice. Ask a pharmacist or prescriber what to do about your specific missed dose.
Storage
Store Fetzima at room temperature, away from moisture and heat.
Side Effects (from patient reports)
Based on 1,858 FDA adverse event reports.
Most-reported reactions
Adverse reactions in FAERS for levomilnacipran, by number of reports
- Pain
Pain
210 reports
- Throwing up
Throwing up
208 reports
- Trouble remembering things
Trouble remembering things
189 reports
- Numbness or tingling
Numbness or tingling
179 reports
- Reduced sense of touch
Reduced sense of touch
178 reports
- Pain in the upper stomach area
Pain in the upper stomach area
175 reports
- Severe headache
Severe headache
170 reports
- Heartburn
Heartburn
168 reports
- Change in taste
Change in taste
157 reports
- Seizures
Seizures
155 reports
What this shows Bars show how often each reaction was reported, not how likely it is to happen, a report records a temporal association, never proof that the drug caused it.
Reports over time
Adverse-event reports filed for levomilnacipran each year to the FDA Adverse Event Reporting System (FAERS).
Year-to-year volume tracks usage, prescribing, and scrutiny, not a change in per-patient risk. Source: FDA FAERS.
Where levomilnacipran sits
levomilnacipran has more FDA adverse-event reports than 12% of the drugs FAERS tracks. A high position reflects how widely a drug is used and watched, not how dangerous it is.
Percentile across all drugs PlainMeds tracks by FAERS report volume. The dot is levomilnacipran; the line is the median (50th percentile).
FDA Adverse Event Report Analysis
Detailed analysis of 1,858 reports from the FDA Adverse Event Reporting System (FAERS). Reports span 2013–2025.
Total Reports
1,858
Reports Mentioning Death
154
8.3% of reports — not proof of cause
Hospitalization Reports
283
Top Indication
Product Used For Unknown Indication
Gender Distribution
Age Distribution
Most Reported Adverse Reactions (FAERS)
| # | Reaction | Reports |
|---|---|---|
| 3 | PAIN | 210 |
| 4 | VOMITING | 208 |
| 5 | MEMORY IMPAIRMENT | 189 |
| 6 | PARAESTHESIA | 179 |
| 7 | HYPOAESTHESIA | 178 |
| 8 | ABDOMINAL PAIN UPPER | 175 |
| 9 | MIGRAINE | 170 |
| 10 | GASTROOESOPHAGEAL REFLUX DISEASE | 168 |
| 12 | TASTE DISORDER | 157 |
| 13 | EPILEPSY | 155 |
| 14 | BLEPHAROSPASM | 152 |
| 15 | NAUSEA | 143 |
| 16 | CONDITION AGGRAVATED | 135 |
| 17 | DEPRESSION | 114 |
| 18 | HEADACHE | 112 |
Reactions in Death Reports
Reactions in Hospitalization Reports
Source: FDA FAERS (Adverse Event Reporting System) FDA FAERS (Adverse Event Reporting System) Reports are voluntary and do not establish causation
Serious Warnings
Antidepressants may increase the risk of suicidal thoughts and behaviors in young adults. Your doctor should closely watch you for worsening depression or suicidal thoughts. Fetzima is not approved for use in children.
Known Drug Interactions
Within 14 days of stopping an MAOI intended to treat psychiatric disorders In a patient who is being treated with linezolid or intravenous methylene blue [see Dosage and Administration ( 2.5 , 2.6 ), Contraindications ( 4 ), and Warnings and Precautions ( 5.2 )] . Examples: selegiline, tranylcypromine, isocarboxazid, phenelzine, linezolid, methylene blue Other Serotonergic Drugs Clinical Impact: Concomitant use of FETZIMA with other serotonergic drugs increases the risk of serotonin syndrome.
Mechanism: Both of these medications increase the levels of a brain chemical called serotonin. If levels get too high, it can lead to a serious and potentially life-threatening reaction.
What to do: Do not take these two medicines together. Your doctor will typically wait at least two weeks after stopping one before starting the other.
Examples: selegiline, tranylcypromine, isocarboxazid, phenelzine, linezolid, methylene blue Other Serotonergic Drugs Clinical Impact: Concomitant use of FETZIMA with other serotonergic drugs increases the risk of serotonin syndrome.
Mechanism: Both drugs increase serotonin levels in the brain, which can lead to a dangerous buildup called serotonin syndrome.
What to do: Do not take these medicines together because the combination can cause serious side effects.
Examples: selegiline, tranylcypromine, isocarboxazid, phenelzine, linezolid, methylene blue Other Serotonergic Drugs Clinical Impact: Concomitant use of FETZIMA with other serotonergic drugs increases the risk of serotonin syndrome.
Mechanism: These drugs both raise serotonin levels, and using them at the same time can cause too much serotonin to build up in your body.
What to do: Avoid using these two drugs together to prevent a potentially dangerous reaction.
Examples: selegiline, tranylcypromine, isocarboxazid, phenelzine, linezolid, methylene blue Other Serotonergic Drugs Clinical Impact: Concomitant use of FETZIMA with other serotonergic drugs increases the risk of serotonin syndrome.
Mechanism: Taking these medications together can cause serotonin levels to become dangerously high, leading to a condition called serotonin syndrome.
What to do: Talk to your doctor before using these together, as this combination is generally avoided.
Examples: other SNRIs, SSRIs, triptans, tricyclic antidepressants, opioids, lithium, buspirone, amphetamines, tryptophan, and St.
Mechanism: Both of these medicines increase the levels of a brain chemical called serotonin. Taking them together can cause serotonin levels to become dangerously high.
What to do: Your doctor should monitor you closely for signs of too much serotonin, such as shivering, sweating, or confusion. Tell your provider immediately if you feel unusual.
This is a plain-language summary of interactions documented in FDA labeling, not individualized advice. Ask a pharmacist or prescriber before combining medications.
Common Questions
What should I do if I feel worse after starting Fetzima?
Can I drink alcohol while taking Fetzima?
What if I have kidney problems?
Can I stop taking Fetzima suddenly?
Will Fetzima affect my other medications?
How long does it take for Fetzima to start working?
What if I have bipolar disorder?
Can Fetzima cause sexual side effects?
What if I need surgery?
Is there a generic version of Fetzima?
What are the common side effects of levomilnacipran?
Does levomilnacipran interact with other medications?
What drug class is levomilnacipran?
Is levomilnacipran safe during pregnancy?
Related Medications in Serotonin-Norepinephrine Reuptake Inhibitor (SNRI)
Other drugs grouped near levomilnacipran - same-class peers and common alternatives.
acamprosate
Campral
Acamprosate is a medicine that can help you stay away from alcohol if you are alcohol-dependent and have already stopped drinking.
Compare with levomilnacipran →
alprazolam
Xanax
Alprazolam (Xanax) is a medication that can help you with anxiety and panic disorders.
Compare with levomilnacipran →
amitriptyline
Elavil
Amitriptyline is a medicine used to treat depression.
Compare with levomilnacipran →
amphetamine/dextroamphetamine
Adderall, Adderall XR
Adderall XR is a stimulant medicine.
Compare with levomilnacipran →
aripiprazole
Abilify
Aripiprazole (Abilify) is a medicine used to treat certain mental disorders and mood problems.
Compare with levomilnacipran →
Medication Guides
Understanding Drug Interactions
How CYP450 enzymes, inhibitors, and inducers affect your medications
Generic vs Brand Name Drugs
FDA requirements, cost savings, and when the difference matters
Narrow Therapeutic Index Drugs
Why some drugs demand precise dosing and monitoring
Common Drug Interactions
Dangerous medication combinations and how to protect yourself
Save on levomilnacipran
Compare prices and find discounts at pharmacies near you. Free coupons can save up to 80% on prescriptions.
Disclosure: This link may earn us a commission at no extra cost to you. See our terms.
What the FDA Data Shows for levomilnacipran
The FDA label for levomilnacipran (sold under brand names such as Fetzima) classifies it as a prescription-only medication in the Serotonin-Norepinephrine Reuptake Inhibitor (SNRI) class. Fetzima is used to treat major depressive disorder (MDD) in adults. Official labeling lists 9 commonly reported side effects, including Nausea, Constipation, Increased sweating.
Post-market surveillance from the FDA Adverse Event Reporting System (FAERS) captures real-world experience. For this drug, FAERS contains 1,858 voluntary reports. The database also lists 11 documented drug interactions derived from FDA labeling, with the top-flagged interaction rated moderate severity. NADAC pricing from CMS.
Report counts do not establish causation, a FAERS entry documents a temporal association, not proof that the drug produced the outcome. Widely prescribed medications naturally accumulate more reports than niche therapies, so raw totals must be interpreted alongside total exposure. Shortage status, recall history, and patent information further shape supply and switching decisions. This page summarizes public FDA data for educational purposes only and is not a substitute for professional medical advice, always consult a licensed healthcare provider before starting, stopping, or changing any medication.
Data Sources
Drug labeling: FDA Drug Labels (SPL/DailyMed). Adverse events: FDA Adverse Event Reporting System (FAERS). Pricing: CMS National Average Drug Acquisition Cost (NADAC).
FAERS reports are voluntary and do not establish causation. Drug interactions are derived from FDA labeling and clinical references. Always consult a healthcare professional before making medication decisions.
Last updated: April 30, 2024
Read our methodology - how this data is sourced, computed, and verified.
Data currency: FDA FAERS adverse-event reports through 2025, CMS NADAC acquisition-cost pricing effective December 2024, compiled and last refreshed May 2026. See our methodology for per-source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
All federal data sources used on this page
- FDA Orange Book - approved drug products with therapeutic equivalence. accessdata.fda.gov/cder/ob
- FDA DailyMed - NIH-hosted drug labeling for FDA-approved meds. dailymed.nlm.nih.gov
- FDA Adverse Event Reporting System (FAERS) - post-marketing safety surveillance. fda.gov/drugs/faers
- NLM RxNorm - standardized clinical drug nomenclature. nlm.nih.gov/research/umls/rxnorm
- CMS Medicare Part B Drug Average Sales Price Files - federal drug pricing data. cms.gov/medicare/part-b-drugs/asp
- FDA Drug Shortages Database - current and resolved drug shortage tracking. accessdata.fda.gov/drugshortages